Rheumatoid arthritis - adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, abatacept and tocilizumab - review [ID537]: committee papers (appendices 4-11)
Rheumatoid arthritis - adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, abatacept and tocilizumab - review [ID537]: committee papers (appendices 4-11)
19 June 2015 (9.49 Mb 10 sec) |
This page was last updated: 19 June 2015